Literature DB >> 9855507

Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging.

K K Baker1, L O Ramig, E S Luschei, M E Smith.   

Abstract

OBJECTIVE: To compare electromyographic (EMG) amplitudes of the thyroarytenoid (TA) muscle in young and older individuals and individuals with idiopathic PD (IPD) under conditions of known vocal loudness (sound pressure level).
BACKGROUND: Voice disorders frequently accompany aging and IPD, but it is unclear how laryngeal muscle physiology is affected by these processes and how changes in laryngeal muscle activity result in characteristic changes of the voice.
METHODS: Absolute and relative (to maximum) EMG amplitudes of the TA muscle were compared during speech and nonspeech tasks. Corresponding sound pressure level (SPL) measures were obtained for the speech tasks.
RESULTS: Absolute TA amplitudes were consistently the highest in the young individuals, lowest in the individuals with IPD, and intermediate in the older individuals. Relative TA amplitudes were generally the highest for the young individuals, lowest for the older individuals, and intermediate for the individuals with IPD. SPL findings showed the older individuals and individuals with IPD produced most of the speech tasks with comparable SPLs, and these levels were consistently lower than those of the young individuals.
CONCLUSIONS: Reduced levels of TA muscle activity may contribute to the characteristic hypophonic voice disorders that frequently accompany IPD and aging.

Entities:  

Mesh:

Year:  1998        PMID: 9855507     DOI: 10.1212/wnl.51.6.1592

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  Instability of syllable repetition as a model for impaired motor processing: is Parkinson's disease a "rhythm disorder"?

Authors:  Sabine Skodda; Andrea Flasskamp; Uwe Schlegel
Journal:  J Neural Transm (Vienna)       Date:  2010-03-18       Impact factor: 3.575

2.  Subthalamic nucleus deep brain stimulation changes speech respiratory and laryngeal control in Parkinson's disease.

Authors:  Michael J Hammer; Steven M Barlow; Kelly E Lyons; Rajesh Pahwa
Journal:  J Neurol       Date:  2010-06-26       Impact factor: 4.849

3.  Basic parameters of articulatory movements and acoustics in individuals with Parkinson's disease.

Authors:  Bridget Walsh; Anne Smith
Journal:  Mov Disord       Date:  2012-01-04       Impact factor: 10.338

4.  Effects of Parkinson's Disease on Fundamental Frequency Variability in Running Speech.

Authors:  Leah K Bowen; Gabrielle L Hands; Sujata Pradhan; Cara E Stepp
Journal:  J Med Speech Lang Pathol       Date:  2013-09

5.  Vocal fold bowing in elderly male monozygotic twins: a case study.

Authors:  Kristine Tanner; Cara Sauder; Susan L Thibeault; Christopher Dromey; Marshall E Smith
Journal:  J Voice       Date:  2009-08-06       Impact factor: 2.009

Review 6.  Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.

Authors:  L Brabenec; J Mekyska; Z Galaz; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-01-18       Impact factor: 3.575

7.  Laryngeal Aerodynamics in Healthy Older Adults and Adults With Parkinson's Disease.

Authors:  Deborah Matheron; Elaine T Stathopoulos; Jessica E Huber; Joan E Sussman
Journal:  J Speech Lang Hear Res       Date:  2017-03-01       Impact factor: 2.297

8.  Age-related effect of cell death on fiber morphology and number in tongue muscle.

Authors:  Heidi Kletzien; Allison J Hare; Glen Leverson; Nadine P Connor
Journal:  Muscle Nerve       Date:  2017-05-16       Impact factor: 3.217

9.  Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease.

Authors:  Sabine Skodda; Wenke Visser; Uwe Schlegel
Journal:  J Neural Transm (Vienna)       Date:  2009-12-12       Impact factor: 3.575

10.  Laryngeal somatosensory deficits in Parkinson's disease: implications for speech respiratory and phonatory control.

Authors:  Michael J Hammer; Steven M Barlow
Journal:  Exp Brain Res       Date:  2009-12-15       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.